Annual Total Long Term Liabilities
$38.30 K
+$38.30 K+100.00%
December 1, 2023
Summary
- As of February 7, 2025, RNAZ annual total long term liabilities is $38.30 thousand, with the most recent change of +$38.30 thousand (+100.00%) on December 1, 2023.
- During the last 3 years, RNAZ annual total long term liabilities has fallen by -$4.02 million (-99.06%).
- RNAZ annual total long term liabilities is now -99.06% below its all-time high of $4.06 million, reached on December 31, 2020.
Performance
RNAZ Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$0.00
$0.000.00%
September 1, 2024
Summary
- As of February 7, 2025, RNAZ quarterly total long term liabilities is $0.00, unchanged on September 1, 2024.
- Over the past year, RNAZ quarterly long term liabilities has dropped by -$189.80 thousand (-100.00%).
- RNAZ quarterly long term liabilities is now -100.00% below its all-time high of $8.09 million, reached on March 31, 2021.
Performance
RNAZ Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
RNAZ Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +100.0% | -100.0% |
3 y3 years | -99.1% | 0.0% |
5 y5 years | -96.9% | - |
RNAZ Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -100.0% | -100.0% | at low |
5 y | 5-year | -99.1% | -100.0% | -100.0% | at low |
alltime | all time | -99.1% | -100.0% | -100.0% | at low |
TransCode Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $0.00(0.0%) |
Jun 2024 | - | $0.00(0.0%) |
Mar 2024 | - | $0.00(-100.0%) |
Dec 2023 | $38.30 K(>+9900.0%) | $38.30 K(-79.8%) |
Sep 2023 | - | $189.80 K(-28.6%) |
Jun 2023 | - | $265.70 K(-29.7%) |
Mar 2023 | - | $377.80 K(>+9900.0%) |
Dec 2022 | $0.00 | $0.00(0.0%) |
Sep 2022 | - | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2022 | - | $0.00(0.0%) |
Mar 2022 | - | $0.00(0.0%) |
Dec 2021 | $0.00(-100.0%) | $0.00(0.0%) |
Sep 2021 | - | $0.00(-100.0%) |
Jun 2021 | - | $5.03 M(-37.9%) |
Mar 2021 | - | $8.09 M(+99.4%) |
Dec 2020 | $4.06 M(+224.4%) | - |
Dec 2020 | - | $4.06 M |
Dec 2019 | $1.25 M | - |
FAQ
- What is TransCode Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics annual total long term liabilities year-on-year change?
- What is TransCode Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for TransCode Therapeutics?
- What is TransCode Therapeutics quarterly long term liabilities year-on-year change?
What is TransCode Therapeutics annual total long term liabilities?
The current annual total long term liabilities of RNAZ is $38.30 K
What is the all time high annual total long term liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high annual total long term liabilities is $4.06 M
What is TransCode Therapeutics annual total long term liabilities year-on-year change?
Over the past year, RNAZ annual total long term liabilities has changed by +$38.30 K (+100.00%)
What is TransCode Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of RNAZ is $0.00
What is the all time high quarterly long term liabilities for TransCode Therapeutics?
TransCode Therapeutics all-time high quarterly total long term liabilities is $8.09 M
What is TransCode Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, RNAZ quarterly total long term liabilities has changed by -$189.80 K (-100.00%)